Beam Therapeutics Overview
Beam Therapeutics Discounted Cash Flow
DCF Analysis for BEAM.
Get informed when a big investor buys or sells
+ FollowFair Value
$-25.93
Current Fair Value
$-25.93
↓ 183.3% Downside
Overvalued by 183.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison